Big Gain For Quince Therapeutics Inc Com
Thu, Oct 24, 2024 at 07:41 PM
Quince Therapeutics Inc Com (QNCX:NASDAQ) shot up at $1.19, representing a gain of 36.8%. On Thu, Oct 24, 2024, QNCX:NASDAQ hit a New 2-Week High of $1.19. The stock got featured on our News Catalysts scanner on Mon, Oct 14, 2024 at 06:42 PM in the 'MISCELLANEOUS' category. From Thu, Oct 10, 2024, the stock recorded 60.00% Up Days and 63.64% Green Days
About Quince Therapeutics Inc Com (QNCX:NASDAQ)
Cortexyme Inc is a clinical-stage biopharmaceutical company developing a disease-modifying therapeutic approach to treat Alzheimer's and other degenerative diseases.
Top 10 Gainers:
- Monopar Therapeutics Inc. (MNPR:NASDAQ), 605.4%
- NXU Inc Cl A (NXU:NASDAQ), 138.68%
- Nexalin Technology Inc. (NXL:NASDAQ), 57.51%
- Alpha Technology Group Limited (ATGL:NASDAQ), 52.45%
- Direxion Daily TSLA Bull 2X Shares (TSLL:NASDAQ), 43.73%
- Top Wealth Group Holding Limited (TWG:NASDAQ), 42.11%
- CCSC Technology International Holdings Limited (CCTG:NASDAQ), 38.51%
- Quince Therapeutics Inc Com (QNCX:NASDAQ), 36.78%
- Click Holdings Limited (CLIK:NASDAQ), 36.73%
- Zoomcar Holdings Inc Com (ZCAR:NASDAQ), 31.52%